Skip to main content
Log in

Symptomkontrolle und ethische Aspekte im terminalen Verlauf einer COPD

Symptom control and ethics in final stages of COPD

  • Fallberichte / Case Reports
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Summary

On the basis of a case study, the complex problems of the final stages of a COPD will be demonstrated and discussed. Dyspnea and anxiousness are the primary symptoms. If they can be adequately brought under control by opiates and benzodiazepines, a palliative sedation is then not necessary. The communicative and ethical demands on the team responsible are high. It is important to be aware of the specific needs of the patient and of his/her family members, and to competently accompany the patient throughout the decision-making process – such as the decision to end respiratory therapy, for example. Clarifying the situation with the patient and finding out his/her wishes, accompanied by the corresponding documentation, is advisable.

Zusammenfassung

Anhand eines Patientenbeispieles werden die komplexen Probleme im terminalen Verlauf einer COPD aufgezeigt und diskutiert. Dyspnoe und Angst sind dabei die vorherrschenden Symptome. Können diese adäquat mit Opioiden und Benzodiazepinen kontrolliert werden, ist eine palliative Sedierung nicht indiziert. Die kommunikativen und ethischen Anforderungen an das betreuende Team sind hoch. Wichtig ist, die spezifischen Bedürfnisse des Patienten und dessen Angehörigen zu kennen und den Patienten in dessen Entscheidungsfindungsprozess – wie hier zum Abbruch der Respiratortherapie – kompetent zu begleiten. Dabei sind Aufklärung, Eruierung des Patientenwillens mit entsprechender Dokumentation empfehlenswert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  • Binsack T (1997) Respiratorische Symptome. In: Aulbert E, Zech D (1997) Lehrbuch der Palliativmedizin. Schattauer, Stuttgart, S600–S609

  • McCord M, Cronin-Strubbs D (1992) Operationalizing dyspnea: focus on measurement. Heart Lung 21: 167–169

    PubMed  CAS  Google Scholar 

  • Steele B, Shaver J (1992) The dyspnea exsperience: nociceptive properties and a model for research and practice. Adv Nurs Sci 15: 64–76

    CAS  Google Scholar 

  • Husebo S, Sandgathe Husebo B (2001) Symptome und Behandlung. In: Die letzten Tage und Stunden. MEDLEX Norwegische Gesundheitsinformation. Oslo, pp 19–20

  • Twycross R (1993) Symptom control: the problem areas. Palliat Med 7[Suppl 1]: 1–8

    Google Scholar 

  • Heyse-Moore LH, Poss V, Mullee MA (1991) How much of a problem is dyspnea in advanced cancer. Palliat Med 5: 20–26

    Google Scholar 

  • Reischl K (2002) Mehr Lebensqualität bei COPD. Ärztewoche 16: 29

    Google Scholar 

  • Claessens MT, Lynn J, Zhong Z et al (2000) Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc 48[Suppl]: 146–153

    Google Scholar 

  • GOLD (2003) The GOLD Workshop Report. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Disease (www.goldcopd.com) (assessed 14 April 2004)

  • Glaxo Smith Kline Pharma GmbH (2004) Lebensbedrohende Exacerbationen – COPD Patienten verschweigen sie. Österreichische Ärztezeitung 20: 62

    Google Scholar 

  • Österreichische Gesellschaft für Pneumomologie ÖGP (2004) Konsensus zum Management der chronisch obstruktiven Lungenerkrankungen (COPD). Wien Klin Wochenschr 116: 268–278

    Article  Google Scholar 

  • Gift AG, Narsavage G (1998) Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 7: 200–204

    PubMed  CAS  Google Scholar 

  • Kellner R, Samet J, Pathak D (1992) Dyspnea, anxiety and depression in chronic respiratory impairment. Gen Hosp Psychiatry 14: 20–28

    Article  PubMed  CAS  Google Scholar 

  • Gore J, Brophy C, Greenstone M (2000) How well do we care for patients with end-stage COPD? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 55: 1000–1006

    Article  PubMed  CAS  Google Scholar 

  • Jonen-Thielemann I (1996) Die Terminalphase. In: Aulbert E, Zech D (Hrsg) Lehrbuch der Palliativmedizin. Schattauer, Stuttgart, pp 678–686

    Google Scholar 

  • Gliemann S (2003) Workshop "Allgemeine Symptomkontrolle". 3. Fachtagung der Bayerischen Stiftung Hospiz, www.bayerische-stiftung-hospiz.de/texte3/vortrag3_t.htm

  • Weixler D (2005) Persönliche Mitteilung: Principle of double effect, Jänner 2005

  • Jennings AJ, Davis AN, Higgins JPT et al (2002) A systematic review of the use of opioids in the management of dyspnea. Thorax 57: 939–944

    Article  PubMed  Google Scholar 

  • Campbell ML, Bizek KS, Thill MC (1999) Patient responses during rapid terminal weaning from mechanical ventilation: a prospective study. Crit Care Med 27: 73–77

    Article  PubMed  CAS  Google Scholar 

  • Weixler D (2003) Palliativmedizin – Sedierung von Sterbenden. In: Weixler D, Paulitsch K (Hrsg) Praxis der Sedierung. Facultas Universitätsverlag, Wien

  • Albrecht E (2004) Respiratorische Symptome – Dyspnoe. In: Bausewein C, Roller S, Voltz R (Hrsg) Leitfaden Palliativmedizin. Urban & Fischer, München, Jena

    Google Scholar 

  • Cowan JD, Walsh D (2001) Terminal sedation in palliative medicine – definition and review of the literature. Support Care Cancer 9: 403–407

    Article  PubMed  CAS  Google Scholar 

  • Müller-Busch C (2004) "Terminale Sedierung" – ein Thema für die Palliativmedizin? Zeitschrift für Palliativmedizin, Georg Thieme, Stuttgart, 29

  • Hardy J (2000) Sedation in terminally ill patients. Lancet 356: 1866–1867

    Article  PubMed  CAS  Google Scholar 

  • Goldstein-Shirley J, Fine PG (2001) "Ethics of Total Sedation". Total Sedation Educational Resources Draft, prepared ba a Task Force of the NHPCO Ethics Committee (Session 8A, March 25, 2001): 1–10

  • Klaschik E (2003) Schmerztherapie und Symptomkontrolle in der Palliativmedizin. In: Husebo S, Klasschik E (Hrsg) Palliativmedizin. Springer, Berlin Heidelberg, S181–S287

    Google Scholar 

  • Müller-Busch CH (2004) Sterbende sedieren? Zeitschrift für Palliativmedizin 4: 107–112

    Article  Google Scholar 

  • Morita T, Miyashita M et al (2004) Emotional burden of nurses in palliative sedation therapy. Palliative Medicine 18: 550–557

    Article  PubMed  Google Scholar 

  • Morita T, Ikenaga M et al (2004) Concerns of family members of patients receiving palliative sedation therapy. Support Care Cancer

  • Cherny NI, Portenoy RK (1994) Sedation in the management of refractory symtoms; guidelines for evaluation and treatment. J Pallit Care 10: 31–38

    CAS  Google Scholar 

  • Stone P, Phillips C, Spruyt O et al (1997) A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 11: 140–144

    PubMed  CAS  Google Scholar 

  • Sykes N (2000) The management of difficult pain and other symptoms at the end of life. Pain in Europe III, advances in pain research and therapy. Nice, France, Abstract ORC/O6: 71–72

  • Fainsinger RL, Bercovici M, Bengtson K et al (2000) A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14: 257–265

    Article  PubMed  CAS  Google Scholar 

  • Roy DJ (1997) Grundlagen der Palliativmedizin. In: Aulbert E, Zech D (Hrsg) Lehrbuch der Palliativmedizin. Schattauer, Stuttgart

    Google Scholar 

  • Materstvedt LJ, Clark D et al (2003) Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force. Palliative Medicine 17: 97–101

    Article  PubMed  Google Scholar 

  • Beleites M (1997) Entwurf der Bundesärztekammer zur ärztlichen Sterbebegleitung und den Grenzen zumutbarer Behandlung. Dtsch Ärzteblatt 94: 1064–1065

    Google Scholar 

  • Eser A et al (1989) Lexikon Medizin-Ethik-Recht. Herder, Freiburg i. Breisgau

  • Meran J (2003) Lebensqualität. Aussichtslosigkeit und Therapiebegrenzung. In: Bonelli J (Hrsg) Imago Hominis. Palliativmedizin I, Imabe, Wien, S19–S28

    Google Scholar 

  • Shee C: Respiratory disease. In: Addington-Hall J, Higginson I (eds) Palliative Care for Non-Cancer Patients. Oxford University Press, Oxford, pp 20–27

  • Breen D, Churches D, Hawker F et al (2002) Acute respiratory failure secondary chronic obstructive pulmonary disease treated in an intensive care unit: a long term follow up study. Thorax 57: 29–33

    Article  PubMed  CAS  Google Scholar 

  • Seneff MG, Wagner DP, Wagner RP et al (1995) Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbations of chronic obstructive pulmonary disease. JAMA 274: 1852–1857

    Article  PubMed  CAS  Google Scholar 

  • Breen D, Churches D, Hawker F et al (2002) Acute respiratory failure secondary chronic obstructive pulmonary disease treated in an intensive care unit: a long term follow up study. Thorax 57: 29–33

    Article  PubMed  CAS  Google Scholar 

  • Nevins ML, Epstein SK (2001) Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest 119: 1840–1849

    Article  PubMed  CAS  Google Scholar 

  • Plant PK, Owen JL, Elliott MW (2000) Early use of non invasive ventilation for acute exacerbations of chronic pulmonary disease on general respiratory wards: a multicentre randomized controlled trial. Lancet 355: 1931–1935, 1936

    Google Scholar 

  • Murtagh F, Preston M, Higginson I (2004) Patterns of dying: palliative care for non malignant disease. Clin Med 4: 39–44

    Article  PubMed  CAS  Google Scholar 

  • Wenger NS, Phillips RS, Teno JM, Oye RK, Dawson NV, Liu H, Califf R, Layde P, Hakim R, Lynn J (2000) Physician understanding of patient resucitation preference: imsights and clinical implications. J Am Geritr Soc 48[5 Suppl]: 44–51

    Google Scholar 

  • Rhodes P (1999) Palliative care: the situation of people with chronic respiratory disease. Br J Community Nurs 4: 131–136

    Google Scholar 

  • Elkington H, White P, Higgs R, Johnson Pettinari C (2001) GP's views of discussions of prognosis in severe COPD. Fam Pract 18: 440–444

    Article  PubMed  CAS  Google Scholar 

  • Lynn J, Ely EW, Zhong Z et al (2000) Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 48: 91–100

    Google Scholar 

  • Blackler L, Mooney C, Jones C (2002) Palliative care in the management of chronic obstructive pulmonary disease. Brit J Nursing 13: 518–521

    Google Scholar 

  • Simonds AK (2003) Occasioinal review: Ethics and decision in making in end stage lung disease. Thorax 58: 272–277

    Article  PubMed  CAS  Google Scholar 

  • Schneidermann LJ, Gilmer T, Teetzel HD (2000) Impact of ethics consultations in the intensive csre setting: arandomised, controlled trial. Crit Care Med 28: 3920–3924

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernadette Hörfarter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hörfarter, B. Symptomkontrolle und ethische Aspekte im terminalen Verlauf einer COPD. Wien Med Wochenschr 156, 275–282 (2006). https://doi.org/10.1007/s10354-006-0289-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-006-0289-2

Keywords

Schlüsselwörter

Navigation